| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
196 |
188 |
$18K |
| 84207 |
|
150 |
148 |
$11K |
| 84425 |
|
154 |
152 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
136 |
133 |
$10K |
| 74246 |
|
68 |
68 |
$10K |
| 82607 |
|
156 |
153 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
156 |
149 |
$6K |
| 83013 |
|
30 |
29 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
103 |
102 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36 |
35 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
91 |
90 |
$3K |
| 86850 |
|
69 |
68 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40 |
38 |
$2K |
| 86901 |
|
69 |
68 |
$1K |
| 86900 |
|
69 |
68 |
$1K |
| 82728 |
|
12 |
12 |
$726.56 |
| 83540 |
|
12 |
12 |
$362.44 |
| 85014 |
|
12 |
12 |
$335.67 |
| 82310 |
|
12 |
12 |
$289.81 |
| 1036F |
|
20 |
16 |
$0.20 |